Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | PFDN5 |
| Upstream (Parents) |
|---|
| (<<) RPL29P11///RPL29P15///RPL29P9///RPL29P26///RPL29P6///RPL29P4///RPL29P31///RPL29P12///RPL29 → PFDN5 |
| (<<) RPL28 → PFDN5 |
| (<<) ATP5G2 → PFDN5 |
| Downstream (Children) |
|---|
| PFDN5 → IMP3 (>>) |
| PFDN5 → TRAPPC2L (>>) |
| PFDN5 → ZNF512B (>>) |
| PFDN5 → ECT2 (>>) |
| PFDN5 → ANXA2 (>>) |
| PFDN5 → DGCR14 (>>) |
| PFDN5 → SERF2 (>>) |
| PFDN5 → RPL29P4///RPL29 (>>) |
| PFDN5 → JMY (>>) |
| PFDN5 → RPL29P11///RPL29P15///RPL29P9///RPL29P26///RPL29P6///RPL29P4///RPL29P31///RPL29P12///RPL29 (>>) |
| PFDN5 → RBM8A (>>) |
| PFDN5 → LOC100131801 (>>) |
| PFDN5 → C12orf62 (>>) |
| PFDN5 → RPL29P11///RPL29P4///RPL29 (>>) |
| PFDN5 → RBM33 (>>) |
| PFDN5 → OST4 (>>) |
| PFDN5 → ARPC3 (>>) |
| PFDN5 → OS9 (>>) |
| PFDN5 → HBA2///HBA1 (>>) |
| PFDN5 → ID1 (>>) |
| PFDN5 → RGS5 (>>) |
| PFDN5 → CFI (>>) |
| PFDN5 → ZNHIT1 (>>) |
| PFDN5 → ATP5G2 (>>) |
| PFDN5 → C19orf42 (>>) |
| PFDN5 → TBRG1 (>>) |
| PFDN5 → CSRP2BP (>>) |
| PFDN5 → HES1 (>>) |
| PFDN5 → PSMB4 (>>) |
| PFDN5 → RPS28P6 (>>) |
| PFDN5 → KRR1 (>>) |
